Literature DB >> 1373787

Plasmapheresis for severe, unremitting, chronic urticaria.

C E Grattan1, D M Francis, N G Slater, R J Barlow, M W Greaves.   

Abstract

Histamine-releasing autoantibodies have been identified in chronic idiopathic urticaria. 8 patients with severe disease and histamine-releasing activity in their sera underwent plasmapheresis. Symptoms were abolished for 2 months in 1 patient and for 3 weeks in another, 2 showed almost complete resolution of symptoms, 2 had temporary relief, and the other 2 showed little change. Further investigation in 4 of the patients showed significantly reduced skin-test responses to fresh post-exchange autologous sera after plasmapheresis compared with stored pre-exchange sera, but the response to intradermal histamine remained unchanged. Blood cellular histamine increased as in-vitro serum histamine-releasing activity fell after plasmapheresis. These results favour a pathogenetic role for histamine-releasing autoantibodies in patients with chronic urticaria.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1373787     DOI: 10.1016/0140-6736(92)90666-q

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  29 in total

Review 1.  Future modalities.

Authors:  M W Greaves
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

Review 2.  Treatment of patients with chronic idiopathic urticaria.

Authors:  Brett E Stanaland
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

3.  [Autoreactive urticaria and autoimmune urticaria].

Authors:  M Maurer; M Metz; M Magerl; F Siebenhaar; P Staubach
Journal:  Hautarzt       Date:  2004-04       Impact factor: 0.751

4.  Healthcare Services Utilization and Drug Use in Patients with Chronic Urticaria.

Authors:  Guy Shalom; Dennis Linder; Doron Comaneshter; Alexandra Nathan; Haim Bitterman; Nancy Agmon-Levin; Arnon D Cohen
Journal:  J Invest Dermatol       Date:  2015-08-24       Impact factor: 8.551

Review 5.  Current and future therapies for the treatment of histamine-induced angioedema.

Authors:  Christine James; Jonathan A Bernstein
Journal:  Expert Opin Pharmacother       Date:  2017-01-25       Impact factor: 3.889

Review 6.  [Chronic spontaneous urticaria: An autoimmune disease?].

Authors:  M Abajian; M Maurer; N Schoepke
Journal:  Hautarzt       Date:  2013-09       Impact factor: 0.751

7.  Chronic Urticaria : Expanding the Autoimmune Kaleidoscope.

Authors:  Y K Sharma; Vinay Gera; V D Tiwari
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 8.  Autoimmune urticaria.

Authors:  Malcolm Greaves
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

9.  Management of difficult urticaria.

Authors:  Sudha Yadav; A K Bajaj
Journal:  Indian J Dermatol       Date:  2009-07       Impact factor: 1.494

10.  Chronic urticaria and treatment options.

Authors:  Kiran Vasant Godse
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.